Åsa Wickberg

Articles in journals

• Hosseini-Mellner, S. , Wickberg, Å. , Karakatsanis, A. & Valachis, A. (2024). Impact of neoadjuvant compared to adjuvant chemotherapy on prognosis in patients with hormone-receptor positive / HER2-negative breast cancer: A propensity score matching population-based study.  Breast, 76. [BibTeX]
• Wickberg, Å. , Prag, C. , Valachis, A. , Karlsson, L. & Johansson, B. (2024). Intraoperative Radiation Therapy Delivered by Brachytherapy in Breast Cancer: An Interim Analysis of a Phase 2 Trial.  Clinical Breast Cancer, 24 (3), 243-252. [BibTeX]
• Olander, S. , Wennstig, A. , Garmo, H. , Holmberg, L. , Nilsson, G. , Blomqvist, C. , Karlsson, F. , Wickberg, Å. & et al. (2023). Angiosarcoma in the breast: a population-based cohort from Sweden.  British Journal of Surgery, 110 (12), 1850-1856. [BibTeX]
• Ohlsson-Nevo, E. , Arvidsson Lindvall, M. , Hellerstedt Börjeson, S. , Hagberg, L. , Hultgren Hörnquist, E. , Valachis, A. , Wickberg, Å. & Duberg, A. (2022). Digitally distributed Yoga Intervention in Breast Cancer Rehabilitation (DigiYoga CaRe): protocol for a randomised controlled trial.  BMJ Open, 12 (11). [BibTeX]
• Wickberg, Å. , Liljegren, G. , Killander, F. , Lindman, H. , Bjöhle, J. , Carlberg, M. , Blomqvist, C. , Ahlgren, J. & et al. (2018). Omitting radiotherapy in women >= 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.  European Journal of Surgical Oncology, 44 (7), 951-956. [BibTeX]
• Wickberg, Å. , Holmberg, L. , Adami, H. , Magnuson, A. , Villman, K. & Liljegren, G. (2014). Reply to a. Levy et Al..  Journal of Clinical Oncology, 32 (29), 3340-3341. [BibTeX]
• Wickberg, Å. , Holmberg, L. , Adami, H. , Magnuson, A. , Villman, K. & Liljegren, G. (2014). Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: 20-Year Results of a Randomized Trial.  Journal of Clinical Oncology, 32 (8), 791-797. [BibTeX]

Conference papers

• Ohlsson-Nevo, E. , Arvidsson Lindvall, M. , Hellerstedt Börjesson, S. , Hagberg, L. , Hultgren Hörnquist, E. , Valachis, A. , Wickberg, Å. & Duberg, A. (2023). A Digitally Distributed Yoga Intervention in Breast Cancer Rehabilitation (DigiYogaCaRe): Protocol for a Randomized Controlled Trial. Paper presented at Nordic Conference in Nursing Research, Reykjavik, Iceland, 2-4 October, 2023. [BibTeX]
• Obondo, C. , Karakatsanis, A. , Eriksson, S. , Hersi, A. F. , Pistiolis, L. , Shahin, A. , Nilsson, F. , Mohammed, I. & et al. (2018). SentiDose - A dose optimizing study with SiennaXP, a superparamagnetic iron oxide for sentinel node detection. In:  European Journal of Cancer. Paper presented at 11th European Breast Cancer Conference (EBCC), Barcelona, Spain, March 21-23, 2018. (pp. S79-S79). Elsevier. [BibTeX]
• Villman, K. , Wickberg, Å. , Killander, F. , Lindman, H. , Bjöhle, J. , Edlund, P. , Tennvall-Nittby, L. , Carlberg, M. & et al. (2017). Omitting radiotherapy in women >= 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe. In:  Cancer Research. American Association For Cancer Research (AACR). [BibTeX]

Doctoral theses, comprehensive summaries

• Wickberg, Å. (2018). Adjuvant treatments to prevent local reurrence after breast-conserving surgery for early breast cancer: radiation, endocrine- or brachytherapy. (Doctoral dissertation). (Comprehensive summary) Örebro: Örebro University. [BibTeX]

Manuscripts

• Wickberg, Å. , Magnuson, A. , Holmgren, L. , Adami, H. & Liljegren, G. Influence of the subtype on local recurrence risk with or without radiotherapy in a randomized trial. [BibTeX]
• Wickberg, Å. , Liljegren, G. , Ahlgren, J. , Karlsson, L. , With, A. & Johansson, B. Intraoperative high dose rate brachytherapy during breast-conserving surgery : a prospective pilot study. [BibTeX]
• Wickberg, Å. , Liljegren, G. , Killander, F. , Lindman, H. , Bjöhle, J. , Carlberg, M. , Blomqvist, C. , Ahlgren, J. & et al. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe. [BibTeX]